Literature DB >> 17409325

Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients.

Charles W Francis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17409325     DOI： 10.1056/NEJMcp067264

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  33 in total

1.  Impact of a student-supported pharmacy assessment program on venous thromboembolism prophylaxis rates in hospitalized patients.

Authors:  Laura E Butkievich; Zachary A Stacy; Michael W Daly; Way Y Huey; Charles T Taylor
Journal:  Am J Pharm Educ       Date:  2010-08-10       Impact factor: 2.047

2.  Dendrigraft of Poly-l-lysine as a Promising Candidate To Reverse Heparin-based Anticoagulants in Clinical Settings.

Authors:  Benjamin Ourri; Jean-Patrick Francoia; Gerald Monard; Jean-Christophe Gris; Julien Leclaire; Laurent Vial
Journal:  ACS Med Chem Lett       Date:  2019-05-08       Impact factor: 4.345

3.  Venous thromboembolism in COPD hospitalized patients.

Authors:  Raquel Barba; Antonio Zapatero; Javier Marco; Juan E Losa; Susana Plaza; Jose Manuel Casas; Jesús Canora
Journal:  J Thromb Thrombolysis       Date:  2012-01       Impact factor: 2.300

Review 4.  [Anticoagulant therapy for chronic cardiac diseases. Atrial fibrillation, valvular heart disease, congestive heart failure].

Authors:  B Witzenbichler
Journal:  Internist (Berl)       Date:  2011-11       Impact factor: 0.743

Review 5.  Cancer, clots and consensus: new understanding of an old problem.

Authors:  Gary H Lyman; Alok A Khorana
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

6.  Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil.

Authors:  Renato D Lopes; Richard C Becker; L Kristin Newby; Eric D Peterson; Elaine M Hylek; Christopher B Granger; Mark Crowther; Tracy Wang; Antonio C Carvalho; Otavio Berwanger; Roberto R Giraldez; Gilson Soares Feitosa; Jorge Pinto Ribeiro; Eduardo Darze; Renato A K Kalil; Marianna Andrande; Fabio Villas Boas; Jadelson Andrade; Ana Thereza Rocha; Robert A Harrington; Antonio C Lopes; David A Garcia
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

Review 7.  Prophylactic and therapeutic anticoagulation for thrombosis: major issues in oncology.

Authors:  Marc Carrier; Agnes Y Y Lee
Journal:  Nat Clin Pract Oncol       Date:  2008-10-28

8.  Inferior vena cava filters for primary prophylaxis: when are they indicated?

Authors:  Eric Wehrenberg-Klee; S William Stavropoulos
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

Review 9.  New options with dabigatran etexilate in anticoagulant therapy.

Authors:  Lars Maegdefessel; Joshua M Spin; Junya Azuma; Philip S Tsao
Journal:  Vasc Health Risk Manag       Date:  2010-05-25

Review 10.  Thrombocytosis in the NICU.

Authors:  David J Powner; W Keith Hoots
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.